About Technology Issues FAQ

Links

Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma

Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.